{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T09:22:40Z","timestamp":1787908960023,"version":"build-2784847793"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T00:00:00Z","timestamp":1682467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T00:00:00Z","timestamp":1682467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Prevention and Treatment of Diseases with Integrated Traditional Chinese and Western Medicine Foundation of Shandong Province"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Mutations in the extracellular matrix gene Fibrillin-2 (FBN2) are related to genetic macular degenerative disorders including age-related macular degeneration (AMD) and early-onset macular degeneration (EOMD). It was reported that the retinal protein expression of FBN2 was reduced in patients with AMD and EOMD. The effect of exogenously supplied fbn2 recombinant protein on fbn2-deficiency-related retinopathy was not known. Here we investigated the efficacy and molecular mechanism of intravitreally applied fibrin-2 recombinant protein in mice with fbn2-deficient retinopathy. The experimental study included groups (all n\u2009=\u20099) of adult C57BL\/6J male mice which underwent no intervention, intravitreal injection of adeno-associated virus (AAV) empty vector or intravitreal injection of AAV-sh-fbn2 (adeno-associated virus for expressing short hairpin RNA for fibrillin-2) followed by three intravitreal injections of fbn2 recombinant protein, given in intervals of 8\u00a0days in doses of 0.30\u00a0\u03bcg, 0.75\u00a0\u03bcg, 1.50\u00a0\u03bcg, and 3.00\u00a0\u03bcg, respectively. Eyes with intravitreally applied AAV-sh-fbn2 as compared to eyes with injection of AAV-empty vector or developed an exudative retinopathy with involvement of the deep retinal layers, reduction in axial length and reduction in ERG amplitudes. After additional and repeated application of fbn2 recombinant protein, the retinopathy improved with an increase in retinal thickness and ERG amplitude, the mRNA and protein expression of transforming growth factor-beta (TGF-\u03b21) and TGF-\u03b2 binding protein (LTBP-1) increased, and axial length elongated, with the difference most marked for the dose of 0.75\u00a0\u03bcg of fbn2 recombinant protein. The observations suggest that intravitreally applied fbn2 recombinant protein reversed the retinopathy caused by an fbn2 knockdown.<\/jats:p>","DOI":"10.1038\/s41598-023-33886-6","type":"journal-article","created":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T15:02:11Z","timestamp":1682521331000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Intravitreal injection of fibrillin 2 (Fbn2) recombinant protein for therapy of retinopathy in a retina-specific Fbn2 knock-down mouse model"],"prefix":"10.1038","volume":"13","author":[{"given":"Rui Xue","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da Dong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu Ru","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gui Min","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing Rong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Wei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen Jun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jost B.","family":"Jonas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong Sheng","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,26]]},"reference":[{"issue":"21","key":"33886_CR1","doi-asserted-by":"publisher","first-page":"5827","DOI":"10.1093\/hmg\/ddu276","volume":"23","author":"R Ratnapriya","year":"2014","unstructured":"Ratnapriya, R. et al. Rare and common variants in extracellular matrix gene fibrillin 2 (FBN2) are associated with macular degeneration. Hum. Mol. Genet. 23(21), 5827\u20135837 (2014).","journal-title":"Hum. Mol. Genet."},{"issue":"6 Pt 1","key":"33886_CR2","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1083\/jcb.103.6.2499","volume":"103","author":"LY Sakai","year":"1986","unstructured":"Sakai, L. Y., Keene, D. R. & Engvall, E. Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils. J. Cell Biol. 103(6 Pt 1), 2499\u20132509 (1986).","journal-title":"J. Cell Biol."},{"issue":"6333","key":"33886_CR3","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/352337a0","volume":"352","author":"HC Dietz","year":"1991","unstructured":"Dietz, H. C. et al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 352(6333), 337\u2013339 (1991).","journal-title":"Nature"},{"issue":"8","key":"33886_CR4","doi-asserted-by":"publisher","first-page":"e22959","DOI":"10.1371\/journal.pone.0022959","volume":"6","author":"S Vierkotten","year":"2011","unstructured":"Vierkotten, S., Muether, P. S. & Fauser, S. Overexpression of HTRA1 leads to ultrastructural changes in the elastic layer of Bruch\u2019s membrane via cleavage of extracellular matrix components. PLoS ONE 6(8), e22959 (2011).","journal-title":"PLoS ONE"},{"issue":"3","key":"33886_CR5","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.ygeno.2003.08.023","volume":"83","author":"GM Corson","year":"2004","unstructured":"Corson, G. M., Charbonneau, N. L., Keene, D. R. & Sakai, L. Y. Differential expression of fibrillin-3 adds to microfibril variety in human and avian, but not rodent, connective tissues. Genomics 83(3), 461\u2013472 (2004).","journal-title":"Genomics"},{"issue":"3","key":"33886_CR6","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.ymthe.2019.12.010","volume":"28","author":"HC Verdera","year":"2020","unstructured":"Verdera, H. C., Kuranda, K. & Mingozzi, F. AAV vector immunogenicity in humans: A long journey to successful gene transfer. Mol. Ther. 28(3), 723\u2013746 (2020).","journal-title":"Mol. Ther."},{"issue":"5","key":"33886_CR7","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1111\/1440-1681.13631","volume":"49","author":"F Xu","year":"2022","unstructured":"Xu, F. et al. Association between anti-fibrillin-2 protein induced retinal degeneration via intravitreous delivery and activated TGF-\u03b2 signalling in mice. Clin. Exp. Pharmacol. Physiol. 49(5), 586\u2013595 (2022).","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"33886_CR8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.neulet.2017.07.041","volume":"657","author":"S Qiu","year":"2017","unstructured":"Qiu, S. et al. Intravitreal injection of docosahexaenoic acid attenuated photoreceptor cell injury in a NaIO3-induced age-related macular degeneration rat model. Neurosci. Lett. 657, 53\u201361 (2017).","journal-title":"Neurosci. Lett."},{"key":"33886_CR9","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.ebiom.2017.02.021","volume":"17","author":"WJ Jiang","year":"2017","unstructured":"Jiang, W. J. et al. Amphiregulin antibody and reduction of axial elongation in experimental myopia. EBioMedicine 17, 134\u2013144 (2017).","journal-title":"EBioMedicine"},{"issue":"3","key":"33886_CR10","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.mcna.2021.01.003","volume":"105","author":"CJ Thomas","year":"2021","unstructured":"Thomas, C. J., Mirza, R. G. & Gill, M. K. Age-related macular degeneration. Med. Clin. N. Am. 105(3), 473\u2013491 (2021).","journal-title":"Med. Clin. N. Am."},{"issue":"1","key":"33886_CR11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41572-021-00265-2","volume":"7","author":"M Fleckenstein","year":"2021","unstructured":"Fleckenstein, M. et al. Age-related macular degeneration. Nat. Rev. Dis. Primer. 7(1), 31 (2021).","journal-title":"Nat. Rev. Dis. Primer."},{"key":"33886_CR12","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.preteyeres.2004.02.003","volume":"23","author":"T Yasukawa","year":"2004","unstructured":"Yasukawa, T. et al. Drug delivery systems for vitreoretinal diseases. Prog. Retin. Eye Res. 23, 253\u2013281 (2004).","journal-title":"Prog. Retin. Eye Res."},{"key":"33886_CR13","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.fob.2015.02.005","volume":"5","author":"W Liu","year":"2015","unstructured":"Liu, W. et al. A novel FBN2 mutation in a Chinese family with congenital contractural arachnodactyly. FEBS Open Bio 5, 163\u2013166 (2015).","journal-title":"FEBS Open Bio"},{"issue":"11","key":"33886_CR14","doi-asserted-by":"publisher","first-page":"3363","DOI":"10.3390\/ijms19113363","volume":"19","author":"GM Tosi","year":"2018","unstructured":"Tosi, G. M., Orlandini, M. & Galvagni, F. The controversial role of TGF-\u03b2 in neovascular age-related macular degeneration pathogenesis. Int. J. Mol. Sci. 19(11), 3363 (2018).","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"33886_CR15","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1083\/jcb.201003089","volume":"190","author":"H Nistala","year":"2010","unstructured":"Nistala, H. et al. Fibrillin-1 and -2 differentially modulate endogenous TGF-\u03b2 and BMP bioavailability during bone formation. J. Cell Biol. 190(6), 1107\u20131121 (2010).","journal-title":"J. Cell Biol."},{"issue":"11","key":"33886_CR16","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1016\/j.ajpath.2017.06.018","volume":"187","author":"A Schlecht","year":"2017","unstructured":"Schlecht, A. et al. Deletion of endothelial transforming growth factor-\u03b2 signaling leads to choroidal neovascularization. Am. J. Pathol. 187(11), 2570\u20132589 (2017).","journal-title":"Am. J. Pathol."},{"key":"33886_CR17","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1042\/bj3520601","volume":"352","author":"R Oklu","year":"2000","unstructured":"Oklu, R. & Hesketh, R. The latent transforming growth factor beta binding protein (LTBP) family. Biochem. J. 352, 601\u2013610 (2000).","journal-title":"Biochem. J."},{"issue":"16","key":"33886_CR18","doi-asserted-by":"publisher","first-page":"5934","DOI":"10.3390\/ijms21165934","volume":"21","author":"L Garc\u00eda-Onrubia","year":"2020","unstructured":"Garc\u00eda-Onrubia, L. et al. Matrix metalloproteinases in age-related macular degeneration (AMD). Int. J. Mol. Sci. 21(16), 5934 (2020).","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"33886_CR19","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1083\/jcb.129.4.1165","volume":"129","author":"H Zhang","year":"1995","unstructured":"Zhang, H., Hu, W. & Ramirez, F. Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils. J. Cell Biol. 129(4), 1165\u20131176 (1995).","journal-title":"J. Cell Biol."}],"updated-by":[{"DOI":"10.1038\/s41598-023-47227-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T00:00:00Z","timestamp":1700006400000}},{"DOI":"10.1038\/s41598-026-67579-7","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-33886-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-33886-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-33886-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T07:23:22Z","timestamp":1787901802000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-33886-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,26]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["33886"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-33886-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,26]]},"assertion":[{"value":"8 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-026-67579-7","URL":"https:\/\/doi.org\/10.1038\/s41598-026-67579-7","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2023","order":9,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":10,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-023-47227-0","URL":"https:\/\/doi.org\/10.1038\/s41598-023-47227-0","order":12,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"6865"}}